Edition:
United Kingdom

Pharmaceuticals

Seattle Genetics Announces Adcetris Approval In Japan

Sept 21 (Reuters) - Seattle Genetics Inc ::SEATTLE GENETICS ANNOUNCES ADCETRIS® (BRENTUXIMAB VEDOTIN) APPROVAL IN JAPAN FOR FRONTLINE HODGKIN LYMPHOMA.SEATTLE GENETICS INC - JAPANESE APPROVAL TRIGGERS MILESTONE PAYMENT TO CO OF $10 MILLION.

Friday, 21 Sep 2018

Morepen Laboratories Gets Shareholders' Nod For Re-Appointment Of Sushil Suri As Chairman And MD

Sept 21 (Reuters) - Morepen Laboratories Ltd ::GETS SHAREHOLDERS' NOD FOR RE-APPOINTMENT OF SUSHIL SURI AS CHAIRMAN AND MD.

Friday, 21 Sep 2018

Mylan Launches Authorized Generic Of Ampyra Tablets

Sept 21 (Reuters) - Mylan NV ::MYLAN LAUNCHES AUTHORIZED GENERIC OF AMPYRA® TABLETS.MYLAN NV - ANNOUNCED U.S. LAUNCH OF DALFAMPRIDINE EXTENDED-RELEASE TABLETS, 10 MG.

Friday, 21 Sep 2018

GSK Says CHMP Recommends Expansion Of Trelegy COPD Label

Sept 21 (Reuters) - GlaxoSmithKline PLC ::GLAXOSMITHKLINE PLC - CHMP RECOMMENDS EXPANSION OF TRELEGY COPD LABEL.GLAXOSMITHKLINE PLC - EMA COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) HAS ISSUED A POSITIVE OPINION TODAY SUPPORTING USE OF TRELEGY ELLIPTA.

Friday, 21 Sep 2018

Expansion & New Markets

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.